A Phase 3 Efficacy and Safety Study of Intra-articular CNTX-4975-05 (Capsaicin) vs Placebo in Subjects With OA Knee Pain

Completed · Phase 3 · Has a placebo group

Conditions studied: Osteoarthritis, Knee

In brief

This is a phase 3, randomized, double-blind, placebo-controlled, single injection, 52-week study to evaluate the analgesic efficacy and safety of a single intra-articular (IA) CNTX-4975-05 (capsaicin), compared to IA placebo, in subjects with chronic, moderate-to-severe osteoarthritis (OA) knee pain.

Key facts

Study ID
NCT03429049
Run by
Centrexion Therapeutics
People needed
332
Starts
2018-01-24
Expected to finish
2019-11-22
Last updated by the study team
2022-07-26

Who can join

Age: 40 and older, up to 95. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.